Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2012-12-13FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for montelukast sodium filed by Rising Pharma Holdings, Inc., indicating approval of a change or add…
-
FDA approval · 2012-12-10FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved the supplemental application for Montelukast Sodium from Dr. Reddy's Laboratories Limited, granting approval for this generic m…
-
FDA approval · 2012-12-10FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for Montelukast Sodium from Dr.Reddy's Laboratories Limited (ANDA201581).
-
FDA approval · 2012-12-05FDA Approved: ALLEGRA-D ALLERGY AND CONGESTION — Supplemental Application (Chattem, Inc.)
FDA approved a supplemental application for Allegra-D Allergy and Congestion (fexofenadine hydrochloride and pseudoephedrine hydrochloride) …
-
FDA approval · 2012-12-05FDA Approved: ALLEGRA-D ALLERGY AND CONGESTION — Supplemental Application (Chattem, Inc.)
FDA approved a supplemental application for Allegra-D Allergy and Congestion (fexofenadine hydrochloride and pseudoephedrine hydrochloride) …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-11-30FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for Montelukast Sodium by Rising Pharma Holdings, Inc., enabling a generic version of Montelukast so…
-
FDA approval · 2012-11-29FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Dr.Reddy's laboratories Ltd.)
FDA approved a supplemental application for levocetirizine dihydrochloride from Dr. Reddy's Laboratories Ltd., granting approval to an exist…
-
FDA approval · 2012-11-29FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved a supplemental application for Levocetirizine Dihydrochloride from Camber Pharmaceuticals, Inc.
-
FDA approval · 2012-11-20FDA Approved: XYZAL — Supplemental Application (Chattem, Inc.)
The FDA approved a supplemental application for XYZAL (levocetirizine dihydrochloride) submitted by Chattem, Inc. The approval updates the d…
-
FDA approval · 2012-11-19FDA Approved: DYMISTA — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for DYMISTA (azelastine hydrochloride and fluticasone propionate) from Viatris Specialty LLC.
-
FDA approval · 2012-11-16FDA Approved: CLARITIN — Supplemental Application (Bayer HealthCare LLC)
The FDA approved a supplemental application for Claritin (loratadine) submitted by Bayer HealthCare LLC.
-
FDA approval · 2012-10-18FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approves a supplemental application for Singulair (montelukast sodium) submitted by Organon LLC.
-
FDA approval · 2012-10-16FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for montelukast sodium from Torrent Pharmaceuticals Limited, enabling the generic product to be mark…
-
FDA approval · 2012-10-16FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for Montelukast Sodium from Torrent Pharmaceuticals Limited.
-
FDA approval · 2012-09-28FDA Approved: CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries, Inc.'s cetirizine hydrochloride and pseudoephedrine hydrochloride as an approved generic product…
-
FDA approval · 2012-09-27FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Singulair (montelukast sodium) submitted by Organon LLC.
-
FDA approval · 2012-09-27FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Singulair (montelukast sodium) submitted by Organon LLC.
-
FDA approval · 2012-09-21FDA Approved: MONTELUKAST SODIUM — Original Application (Accord Healthcare Inc.)
FDA approved Accord Healthcare Inc.'s Montelukast Sodium Original Application under ANDA 202717, granting a generic version of montelukast s…
-
FDA approval · 2012-09-18FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for montelukast sodium from Lannett Company, Inc., indicating approval of a supplemental (generic) f…
-
FDA approval · 2012-08-23FDA Approved: ALLEGRA-D ALLERGY AND CONGESTION — Supplemental Application (Chattem, Inc.)
FDA approves a supplemental NDA for Allegra-D Allergy and Congestion, submitted by Chattem, Inc., concerning fexofenadine hydrochloride and …
-
FDA approval · 2012-08-23FDA Approved: CHILDRENS ALLEGRA ALLERGY — Supplemental Application (Chattem, Inc.)
FDA approved a supplemental application to update the labeling for Children's Allegra Allergy (fexofenadine hydrochloride), expanding its pe…
-
FDA approval · 2012-08-21FDA Approved: FLONASE SENSIMIST ALLERGY RELIEF — Supplemental Application (Haleon US Holdings LLC)
The FDA approved a supplemental application for Flonase Sensimist Allergy Relief (fluticasone furoate) from Haleon US Holdings LLC.
-
FDA approval · 2012-08-10FDA Approved: DYMISTA — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for DYMISTA (azelastine hydrochloride and fluticasone propionate) submitted by Viatris Specialty LLC…
-
FDA approval · 2012-08-03FDA Approved: MONTELUKAST SODIUM — Original Application (Rising Pharma Holdings, Inc.)
FDA approved the original application for a generic montelukast sodium product from Rising Pharma Holdings, Inc. under ANDA 202468.
-
FDA approval · 2012-08-03FDA Approved: MONTELUKAST — Original Application (Sandoz Inc)
FDA approved Sandoz's original ANDA for montelukast, establishing a generic version of the leukotriene receptor antagonist for prevention of…